Cynosure Advisors’s Oracle ORCL Stock Holding History

Cynosure Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,143	Closed	-$447K	–	140
2018 Q2	$447K	Hold	10,143	–	–	0.12%	119
2018 Q1	$464K	Buy	10,143 +100	+1%	+$4.97K	0.12%	100
2017 Q4	$475K	Buy	+10,043	New	+$493K	0.11%	115

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cynosure Advisors's ORCL Position: Q3 2018 in Review

Cynosure Advisors sold out of Oracle (ORCL) in Q3 2018, closing a stake of 10,143 shares — an estimated $447K sold.

Cynosure Advisors first reported a position in ORCL in Q4 2017 and held it in 3 quarters. The position peaked at $475K in Q4 2017. 1,708 funds tracked by Wall St. Rank hold ORCL as of Q3 2018.

Cynosure Advisors reported no remaining Oracle position as of Q3 2018 after selling out during the quarter.
Cynosure Advisors sold 10,143 Oracle shares in Q3 2018, an estimated $447K.
Cynosure Advisors first reported a position in Oracle in Q4 2017 and held it in 3 quarters.
Cynosure Advisors's Oracle position peaked at $475K in Q4 2017.
1,708 funds tracked by Wall St. Rank held Oracle as of Q3 2018.

Based on Cynosure Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.